BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37897648)

  • 21. Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.
    Sabatier R; Sabiani L; Zemmour C; Taix S; Chereau E; Gonçalves A; Jalaguier-Coudray A; Charafe-Jauffret E; Resbeut M; Extra JM; Viens P; Tallet A
    Breast; 2016 Jun; 27():8-14. PubMed ID: 27212694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.
    Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D
    World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 36 cases adenoid cystic carcinoma of the breast in China: Comparison with matched grade one invasive ductal carcinoma-not otherwise specified.
    Wang S; Li W; Wang F; Niu Y; Hao C; Wang X; He L; Tong Z
    Pathol Res Pract; 2017 Apr; 213(4):310-315. PubMed ID: 28222936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.
    Lei T; Yang Y; Shi Y; Deng X; Peng Y; Wang H; Chen T
    Diagn Pathol; 2022 Dec; 17(1):101. PubMed ID: 36585729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis.
    Osako T; Takeuchi K; Horii R; Iwase T; Akiyama F
    Histopathology; 2013 Oct; 63(4):509-19. PubMed ID: 23944930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological Relevance and Prognostic Value of Androgen Receptor in Mammary Paget's Disease with Underlying Invasive Ductal Carcinoma.
    Zhang M; Meng X; Guo C; Liu J; Xing Z; Wang X; Wang X
    Oncol Res Treat; 2020; 43(7-8):346-353. PubMed ID: 32645702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of extranodal extension in axillary lymph node-positive breast cancer.
    Ma X; Yang X; Yang W; Shui R
    Sci Rep; 2021 May; 11(1):9534. PubMed ID: 33953240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers.
    Wang M; Liang L; Lei X; Multani A; Meric-Bernstam F; Tripathy D; Wu Y; Chen H; Zhang H
    Ann Diagn Pathol; 2018 Aug; 35():69-76. PubMed ID: 29843069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The comparison of characters between invasive micropapillary carcinoma and invasive ductal carcinoma not otherwise specified of the breast].
    Hua B; Lu X; Xiao WZ; He SR; Wang Z
    Zhonghua Wai Ke Za Zhi; 2017 Oct; 55(10):770-774. PubMed ID: 29050179
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
    Yang X; Tang T; Zhou T
    World J Surg Oncol; 2023 Nov; 21(1):364. PubMed ID: 37996840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
    Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
    Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
    Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
    Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological Features and Prognosis of Invasive Micropapillary Carcinoma Compared to Invasive Ductal Carcinoma-NOS: Worse or Better?
    Aker FV; Ekren E; Dogan M; Gurleyik G; Tanrikulu E; Oven BB
    J Coll Physicians Surg Pak; 2022 Sep; 32(9):1196-1201. PubMed ID: 36089720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathological features and prognosis of breast cancer with human epidermal growth factor receptor 2 low expression].
    Zhu XJ; Zhang H; Zhang S; Li D; Li X; Xu L; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):243-253. PubMed ID: 37042134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast-Conserving Surgery in Patients With Mammary Paget's Disease.
    Yao Y; Sun L; Meng Y; Zhuang Y; Zhao L; Yu Q; Si C
    J Surg Res; 2019 Sep; 241():178-187. PubMed ID: 31026796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
    Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
    Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
    Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
    Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.
    Zhao H; Yang M; Zhao J; Wang J; Zhang Y; Zhang Q
    Med Oncol; 2013 Mar; 30(1):475. PubMed ID: 23371253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.